`
`Filed On Behalf Of:
`Novartis Pharmaceuticals Corporation
`
`By:
`Nicholas N. Kallas
`nkallas@Venable.com
`(212) 218-2243
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`BIOCON PHARMA LIMITED,
`Petitioner,
`
`v.
`
`NOVARTIS PHARMACEUTICALS CORPORATION,
`Patent Owner.
`
`Case IPR2020-01263
`Patent 8,101,659
`
`PATENT OWNER’S POWER OF ATTORNEY
`UNDER 37 C.F.R. § 42.10(b)
`
`
`
`POWER OF ATTORNEY IN AN INTER PARTES REVIEW
`
`Patent Owner Novanis Phannaceuticals Corporation (“Novartis‘”) hereby
`
`appoints Nicholas N. Kallas (Reg. No. 31,530), Christina Schwarl. (Reg. No.
`
`78.484), Shannon Clark (Reg. No. 69.787) and Laura K. liishwick (Reg. No.
`
`69,907) as its attorneys to prosecute the aforementioned proceeding and to transact
`
`all business in the United States Patent and Trademark Office connected therewith.
`
`Please address all correspondence as follows:
`
`Nicholas N. Kallas
`
`Venable LLP
`
`1290 Avenue of the Americas
`
`New York, NY 10104
`Telephone: (212) 218-2243
`Facsimile: (212) 218-2200
`nkallas@Venable.com
`
`
`Dated: August 27, 2020
`
`
`
` Peter J.
`Head, US Patent Litigation
`Novartis Pharmaceuticals Corporation
`One Health Plaza
`
`aibel
`
`East Hanover, NJ 07936-1080
`
`